ArticleAesthetic plastic surgery2026
Evaluation of the Efficacy and Safety of Injectable Cross-Linked Sodium Hyaluronate Gel Containing Lidocaine for Correcting Infraorbital Hollowing.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecently, hyaluronic acid-based soft tissue fillers have gradually become one of the preferred treatment strategies for the correction of infraorbital hollowing (IH). This study aims to evaluate the efficacy and safety of injectable cross-linked sodium hyaluronate gel containing lidocaine for correcting IH.
methodsA total of 33 patients with moderate or severe IH who received injection treatment with injectable cross-linked sodium hyaluronate gel containing lidocaine were enrolled and followed up periodically. Allergan Infraorbital Hollowing Scale (AIHS), changes in infraorbital volume (IV), Global Aesthetic Improvement Scale (GAIS), patient satisfaction, dark circle disturbance, and laboratory test results were utilized to evaluate its efficacy and safety in correcting IH.
results96.97% of patients showing an improvement of ≥1 grade at 3 months after the last treatment. The patient satisfaction at 1 month, 3 months, and 6 months after the last injection was 94.5%, 84.85%, and 96.97%, respectively. Compared with baseline, IV increased on the left side in 87.88% of patients and on the right side in 78.79% of patients. Improvements in overall cosmetic outcomes were observed in all patients. Additionally, the proportion of patients reporting no disturbance or no dark circles after treatment increased significantly, while those with moderate or severe disturbance reported only minor disturbance after treatment.
conclusionInjectable cross-linked sodium hyaluronate gel containing lidocaine can correct moderate to severe IHs to a certain extent and is a filler with clinical application potential. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42509280What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.